Innovent Biologics Eulerpool News

Innovent Biologics Stock News

Innovent Biologics is being monitored by journalists and investors worldwide. We gather the latest Innovent Biologics news here.

• October 1 ·

  Yahoo
  Asian Market Value Opportunities: Three Stocks To Watch In September 2025
• September 19 ·

  Yahoo
  Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes
• September 10 ·

  Yahoo
  Innovent Biologics (SEHK:1801) Partners With Fangzhou For AI-Driven Diabetes Care In China
• July 30 ·

  SeekingAlpha
  Novo Nordisk: Is This An Overreaction Or The End Of The GLP-1 Fairy Tale?
• July 8 ·

  Yahoo
  Health Care Roundup: Market Talk
• July 4 ·

  Yahoo
  3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 47.8%
• June 30 ·

  Yahoo
  Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms
• June 27 ·

  Yahoo
  Innovent Announces Mazdutide, First Dual GCG/GLP-1 Receptor Agonist, Received Approval from China's NMPA for Chronic Weight Management
• June 23 ·

  SeekingAlpha
  Neutral On Innovent Biologics: Hard To Justify Its Premium
• June 17 ·

  Yahoo
  High Growth Tech Stocks in Asia Featuring 3 Promising Picks